Literature DB >> 7794112

Serological recognition of feline infectious peritonitis virus spike gene regions expressed as synthetic peptides and E. coli fusion protein.

B T Suiter1, N E Pfeiffer, E V Jones, A P Reed, S R Klepfer, T J Miller, S Srikumaran.   

Abstract

Cats exposed to feline infectious peritonitis virus (FIPV) or feline enteric coronavirus (FECV) cannot be differentiated by serological analysis. Three synthetic peptides and an E. coli recombinant fusion protein generated from FIPV 79-1146 spike gene sequence were produced. Coronavirus positive cat sera reacted to peptide aa 950-990 but were non-reactive to aa137-151 and aa 150-180 peptides as demonstrated by ELISA. Amino acid sequence 97-222 expressed as a galk fusion protein in E. coli was tested against coronavirus positive cat sera by western blot analysis. Only sera from cats exposed to the FIPV type-II strains DF-2 or 79-1146 that were exhibiting signs of FIP recognized the fusion protein. Sera from FECV exposed cats did not recognize the 97-222 fusion protein in western blot analysis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7794112      PMCID: PMC7086793          DOI: 10.1007/bf01309958

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  26 in total

1.  Antigenic structure of transmissible gastroenteritis virus. II. Domains in the peplomer glycoprotein.

Authors:  B Delmas; J Gelfi; H Laude
Journal:  J Gen Virol       Date:  1986-07       Impact factor: 3.891

2.  The antigenic index: a novel algorithm for predicting antigenic determinants.

Authors:  B A Jameson; H Wolf
Journal:  Comput Appl Biosci       Date:  1988-03

3.  Analysis of an immunodominant region of infectious bronchitis virus.

Authors:  J G Kusters; E J Jager; J A Lenstra; G Koch; W P Posthumus; R H Meloen; B A van der Zeijst
Journal:  J Immunol       Date:  1989-10-15       Impact factor: 5.422

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization.

Authors:  H Vennema; R J de Groot; D A Harbour; M Dalderup; T Gruffydd-Jones; M C Horzinek; W J Spaan
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

6.  Vaccination against lethal coronavirus-induced encephalitis with a synthetic decapeptide homologous to a domain in the predicted peplomer stalk.

Authors:  P J Talbot; G Dionne; M Lacroix
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

7.  Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide.

Authors:  E A Emini; J V Hughes; D S Perlow; J Boger
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

8.  The nucleotide sequence of the peplomer gene of porcine transmissible gastroenteritis virus (TGEV): comparison with the sequence of the peplomer protein of feline infectious peritonitis virus (FIPV).

Authors:  L Jacobs; R de Groot; B A van der Zeijst; M C Horzinek; W Spaan
Journal:  Virus Res       Date:  1987-11       Impact factor: 3.303

9.  Protection against feline infectious peritonitis by intranasal inoculation of a temperature-sensitive FIPV vaccine.

Authors:  J D Gerber; J D Ingersoll; A M Gast; K K Christianson; N L Selzer; R M Landon; N E Pfeiffer; R L Sharpee; W H Beckenhauer
Journal:  Vaccine       Date:  1990-12       Impact factor: 3.641

10.  Evidence for a coiled-coil structure in the spike proteins of coronaviruses.

Authors:  R J de Groot; W Luytjes; M C Horzinek; B A van der Zeijst; W J Spaan; J A Lenstra
Journal:  J Mol Biol       Date:  1987-08-20       Impact factor: 5.469

View more
  1 in total

1.  Detection of antibodies against SARS-CoV in serum from SARS-infected donors with ELISA and Western blot.

Authors:  Yue-Dan Wang; Yan Li; Guo-Bin Xu; Xue-Yuan Dong; Xiao-Ang Yang; Zhen-Ru Feng; Chan Tian; Wei Feng Chen
Journal:  Clin Immunol       Date:  2004-11       Impact factor: 3.969

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.